Med-Care Infusion Services, Inc.

Med-Care Infusion Services, Inc., operating under the alias Med-Care Infusion Services, is a specialty pharmacy that focuses on providing infusion therapies to patients. As a specialty pharmacy, the organization dispenses high‑cost, complex medications that require specialized handling and administration. Its services are intended for individuals who need intravenous, subcutaneous, or other parenteral drug delivery that cannot be managed through conventional retail pharmacies. The company’s headquarters is located in the United States of America, indicating that its primary market and regulatory environment are domestic. It serves patients across various therapeutic areas where infusion treatment is standard, although specific geographic reach or patient volume figures are not disclosed in the available sources.

The source material does not provide explicit quantitative details about the organization’s size, such as the number of employees, annual revenue, or number of facilities. Because no public filings, press releases, or other disclosures were cited, any statement about scale would be speculative and therefore omitted. Consequently, the profile can only confirm the organization’s existence as a specialty pharmacy within the United States without further metrics. The absence of disclosed scale information means that descriptions of its reach or footprint must remain general and unverified.

Med-Care Infusion Services distinguishes itself by concentrating on infusion‑based specialty pharmacy services, a niche that requires expertise in sterile compounding and patient support. The organization’s role in the healthcare supply chain involves managing medications that are often biologics, chemotherapy agents, or immunomodulators. In October 2020, the company experienced a ransomware attack carried out by the DoppelPaymer threat group. During the incident, the attackers exfiltrated data and posted two non‑sensitive documents on their leak site as proof of access. Although the leaked materials did not contain personally identifiable information or protected health information, the breach highlighted vulnerabilities in the organization’s cybersecurity defenses. Med-Care Infusion Services did not issue any public notifications or warnings about the attack, nor did it respond to multiple inquiries from journalists or regulators at the time of reporting. This lack of communication contributed to uncertainty about the full impact of the incident on patients and partners.